| 名稱(chēng) | NCOA4(E8)-RET(E12) Fusion 標(biāo)準(zhǔn)品 |
| 型號(hào) | CBP20180R |
| 報(bào)價(jià) |  |
| 特點(diǎn) | NCOA4(E8)-RET(E12) Fusion |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Fusion > CBP20180RNCOA4(E8)-RET(E12) Fusion 標(biāo)準(zhǔn)品
- 詳細(xì)內(nèi)容
CBP20180R | |
| Format | RNA |
| Description | NCOA4, nuclear receptor coactivator 4, is an androgen receptor coactivator (PMID: 15166229) and autophagy receptor that degrades ferritin complexes (PMID: 31061094) and plays a role in iron homeostasis (PMID: 30930742). NCOA4 fusions are frequently observed with RET in papillary thyroid carcinoma (also referred to as RET/PTC3) (PMID: 25731779) and have been reported in salivary intraductal carcinoma (PMID: 31162284), spindle cell tumors (PMID: 30938880), breast cancer (PMID: 30446652), colorectal cancer (PMID: 30210625), and lung cancer (PMID: 30038711). |
| Technical Data | |
| Left Gene | NCOA4 |
| Left Breakpoint | chr10:51582939:+ |
| Right Gene | RET |
| Right Breakpoint | chr10:43612032:+ |
| Cosmic ID | COSF1491 |
| Buffer | RNase-free H2O |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| RNA electrophoresis | Download for COA |
| Sanger sequencing | Download for COA |
| Storage | -80℃ |
| Expiry | 12 months from the date of manufacture |
" _ue_custom_node_="true">
會(huì)員_a.png)